Equities

Shandong Weigao Orthopaedic Device Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shandong Weigao Orthopaedic Device Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (CNY)29.80
  • Today's Change-0.16 / -0.53%
  • Shares traded796.77k
  • 1 Year change+12.62%
  • Beta1.4855
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Shandong Weigao Orthopaedic Device Co Ltd is a China-based company mainly engaged in the research and development, production and sales of orthopedic medical devices. The Company's products include orthopedic implanted medical devices and orthopedic surgical instruments. The Company's products cover various orthopedic implanted medical device fields such as spine, trauma, joint and sports medicine, among others. The Company mainly conducts its businesses within domestic market.

  • Revenue in CNY (TTM)1.48bn
  • Net income in CNY266.86m
  • Incorporated2005
  • Employees2.07k
  • Location
    Shandong Weigao Orthopaedic Device Co LtdNo. 26 Xiangjiang Street, Tourist ResortWEIHAI 264209ChinaCHN
  • Phone+86 6 315788909
  • Fax+86 6 315660958
  • Websitehttp://www.wegortho.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Shanghai Haohai Biological Tech Co Ltd2.52bn384.21m10.07bn2.16k28.731.94--3.991.651.6510.8324.490.35121.537.841,169,728.004.944.585.965.2669.1370.3914.0714.673.24--0.065642.371.6410.951.042.55-1.8614.87
Qingdao Haier Biomedical Co Ltd2.26bn255.88m10.34bn2.81k40.102.40--4.570.81440.81447.2113.640.40084.315.12806,199.104.6810.875.9214.1245.3149.2111.6724.082.41--0.020528.140.128817.67-9.7115.03-5.5321.16
Xiangyu Medical Co Ltd773.93m73.51m10.71bn2.34k139.835.29--13.840.47890.47895.0712.670.25481.0111.40330,597.702.358.543.2610.1765.9866.789.2228.370.9871--0.238732.49-0.171711.71-54.68-4.4183.55--
Shanghai Microport EP MedTech Co Ltd458.70m52.26m11.05bn500.00211.536.17--24.100.1110.1110.97473.810.23951.336.85917,403.002.730.90842.910.957958.2464.9511.394.0910.17--0.00320.0025.5128.61815.36--35.67--
TINAVI Medical Technologies Co Ltd274.20m-159.01m11.23bn307.00--8.99--40.96-0.3493-0.34930.60352.740.16732.187.63893,155.40-10.37-8.02-11.54-9.1670.0969.64-62.01-63.512.94-15.750.1408---14.85-4.8722.54--12.71--
Beijing Wandong Medical Technolgy Co Ltd1.62bn14.41m11.28bn1.19k963.392.41--6.970.01670.01672.266.660.29372.732.991,360,016.000.26234.510.3045.2131.5942.820.893314.914.80--0.003943.2523.269.18-16.54-1.40-1.3921.06
Sansure Biotech Inc1.67bn271.49m11.59bn2.35k45.181.63--6.940.44270.44272.4512.310.18521.042.46711,687.902.5021.182.8124.3773.7068.6013.4940.514.49--0.171625.7444.7831.89-24.2347.5065.28--
Eyebright Medical Technlgy (Bjng) Co Ltd1.48bn360.97m11.75bn2.29k32.254.18--7.941.881.887.7114.530.40481.893.34644,799.409.9010.5011.5412.0462.9175.1324.4531.923.2824.660.175320.1148.2448.5127.7742.2518.40--
Vcanbio Cell & Gene Engineering Corp Ltd1.47bn74.75m11.91bn2.01k154.493.21--8.090.16470.16473.297.930.27781.922.35730,874.401.071.241.511.7667.2968.073.854.201.604.900.02190.00-0.27052.71-5.7315.09-11.35--
Shandong Weigao Orthopaedic Devce Co Ltd1.48bn266.86m11.98bn2.07k44.902.94--8.120.66720.66723.7010.180.29190.77985.17714,278.405.369.006.5811.0564.2274.0718.3724.984.28--0.001122.9013.18-1.5999.22-12.72-3.40--
Shanghai MicroPort Edvcl MdTch Grp CoLtd1.25bn377.82m12.23bn832.0031.863.09--9.773.123.1210.2732.100.26941.563.661,515,185.007.9415.389.1016.8768.1075.3829.4541.854.36--0.004346.521.6129.301.9628.7858.5335.76
Beijing Hotgen Biotech Co Ltd434.45m-259.33m12.62bn903.00--4.30--29.06-3.04-3.044.9831.630.13131.964.23481,114.30-7.9721.79-8.4724.9356.3855.43-60.7129.144.77--0.016844.35-6.7419.41-760.40---10.29--
Data as of Feb 06 2026. Currency figures normalised to Shandong Weigao Orthopaedic Device Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

0.90%Per cent of shares held by top holders
HolderShares% Held
Bosera Asset Management Co., Ltd.as of 30 Jun 20251.13m0.28%
China Asset Management Co., Ltd.as of 30 Jun 2025673.78k0.17%
Penghua Fund Management Co., Ltd.as of 30 Jun 2025629.24k0.16%
Yinhua Fund Management Co., Ltd.as of 30 Jun 2025283.23k0.07%
Maxwealth Fund Management Co., Ltd.as of 30 Jun 2025216.54k0.05%
E Fund Management Co., Ltd.as of 30 Jun 2025210.29k0.05%
Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025139.94k0.04%
Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 2025137.32k0.03%
Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 202594.89k0.02%
Guotai Asset Management Co., Ltd.as of 30 Jun 202588.29k0.02%
More ▼
Data from 30 Jun 2025 - 29 Jan 2026Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.